Halozyme Therapeutics reported $112.1M in Trade Debtors for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acadia Pharmaceuticals ACAD:US $ 61.67M 9.85M
Agios Pharmaceuticals AGIO:US $ 6.99M 1.14M
Alnylam Pharmaceuticals ALNY:US $ 141.06M 505.52M
Amarin AMRN:US $ 149.36M 32.9M
Amgen AMGN:US $ 4765M 286M
Aptinyx Inc APTX:US $ 0 0
Baxter International BAX:US $ 2074M 53M
Cara Therapeutics CARA:US $ 21.05M 20.04M
Eli Lilly And LLY:US $ 7025M 122.2M
Esperion Therapeutics ESPR:US 21.71M 144K
Halozyme Therapeutics HALO:US $ 112.1M 41.1M
Intra Cellular Therapies ITCI:US $ 16.93M 1.75M
Intrexon XON:US $ 21.08M 5.59M
JAZZ PHA JAZZ:US $ 499.02M 7.64M
Mannkind MNKD:US $ 9.44M 3.14M
Nektar Therapeutics NKTR:US $ 28.99M 0.12M
Rigel Pharmaceuticals RIGL:US $ 14.99M 2.38M
United Therapeutics UTHR:US $ 212.8M 39.4M
Vanda Pharmaceuticals VNDA:US $ 41.5M 4.41M